These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2098307)

  • 21. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-interferon in the treatment of idiopathic myelofibrosis.
    List AF; Doll DC
    Br J Haematol; 1992 Apr; 80(4):566-7. PubMed ID: 1581246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beneficial effect of interferon alfa-2a in a case of splenic lymphoma with circulating villous cells].
    Ferrer Marco R; Ruiz Guinaldo MA; Martínez Martínez J; Navarro Gonzalo I
    Sangre (Barc); 1993 Dec; 38(6):503-4. PubMed ID: 8171390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Efficacy of intralesional interferon in the reduction of extramedullary masses in a case of lymphoblastic leukosis].
    Alba P; Franco R; Caballero D; León A
    Sangre (Barc); 1991 Jun; 36(3):250. PubMed ID: 1948548
    [No Abstract]   [Full Text] [Related]  

  • 25. Alpha interferon in systemic sclerosis.
    Shah VM; Mangat GK; Joshi VR
    J Assoc Physicians India; 2001 Jun; 49():676-7. PubMed ID: 11584956
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolymphocytic leukemia: a very satisfactory response to treatment with recombinant interferon alpha.
    Vivaldi P; Garuti R; Rubertelli M; Mazzon C
    Haematologica; 1992; 77(2):169-70. PubMed ID: 1398302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.
    Buxhofer-Ausch V; Gisslinger H; Berg T; Gisslinger B; Kralovics R
    Eur J Haematol; 2009 Feb; 82(2):161-3. PubMed ID: 19018861
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experience with the treatment of metastatic renal cell carcinoma with subcutaneous interleukin-2r (IL-2r) and interferon Alpha-2b (IFN Alfa-2b)].
    Olivier C; Carballido J; Lao AH; Gimeno A; Martín C; Renjifo D; Ondina LM; Manzano L; Alvarez-Mon M
    Actas Urol Esp; 1995 Jan; 19(1):16-26. PubMed ID: 7717154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia.
    Almasio P; Mirto S; Malleo C; Di Marco V; Caronia F; Craxi A
    Haematologica; 1991; 76(5):429-30. PubMed ID: 1806450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant interferon alpha in renal carcinoma with a high risk of recurrence. Multicenter pilot study].
    Pizzocaro G; Piva L; Faustini M; Nicolai N; Salvioni R; Pisani E; Maggioni A; Mandressi A; Dormia E; Minervini S
    Arch Ital Urol Androl; 1993 Apr; 65(2):173-6. PubMed ID: 8330063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with alpha-interferon.
    Domingues MA; Haepers AT; Massaut IH; Vassallo J; Lorand-Metze I
    Haematologica; 1998 Dec; 83(12):1124-5. PubMed ID: 9949632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of myelofibrosis with alfa-interferon.
    McCarthy D; Clark J; Giles F
    Br J Haematol; 1991 Aug; 78(4):590-1. PubMed ID: 1911363
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon alfa therapy in CALR-mutated essential thrombocythemia.
    Cassinat B; Verger E; Kiladjian JJ
    N Engl J Med; 2014 Jul; 371(2):188-9. PubMed ID: 25006741
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha.
    Kumari P; Schechter GP; Saini N; Benator DA
    Clin Infect Dis; 2000 Aug; 31(2):602-4. PubMed ID: 10987728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experiences with interferon-alpha and interferon-gamma.
    Steinmann GG; Rosenkaimer F; Leitz G
    Int Rev Exp Pathol; 1993; 34 Pt B():193-207. PubMed ID: 8458713
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modulation by recombinant alpha-2a-interfer on the activity and site of action of 5-fluorouracil on xenografted human colon cancer in nude mice: preliminary report].
    Yoshida K; Fujikawa T; Tanabe A; Sakurai K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):559. PubMed ID: 1614401
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon-alpha in cardiac Erdheim-Chester disease.
    Monti L; Haroche J; Sciarra A; Balzarini L; Fiamengo B; Amoura Z; Graziani G
    J Am Coll Cardiol; 2011 Dec; 58(25):2695. PubMed ID: 22152958
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon-alpha in the management of patients with Behçet's disease.
    Yang DS; Taylor SR; Lightman SL
    Br J Hosp Med (Lond); 2008 Oct; 69(10):575-9. PubMed ID: 18949947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.